{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:43:24Z","timestamp":1786581804260,"version":"build-2736575974"},"reference-count":138,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the National Health Laboratory Service Research Trust Grant","award":["GRANT004_94877"],"award-info":[{"award-number":["GRANT004_94877"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>Viruses are minuscule infectious agents that reproduce exclusively within the living cells of an organism and are present in almost every ecosystem. Their continuous interaction with humans poses a significant threat to the survival and well-being of everyone. Apart from the common cold or seasonal influenza, viruses are also responsible for several important diseases such as polio, rabies, smallpox, and most recently COVID-19. Besides the loss of life and long-term health-related issues, clinical viral infections have significant economic and social impacts. Viral enzymes, especially proteases which are essential for viral multiplication, represent attractive drug targets. As a result, screening of viral protease inhibitors has gained a lot of interest in the development of anti-viral drugs. Despite the availability of anti-viral therapeutics, there is a clear need to develop novel curative agents that can be used against a given virus or group of related viruses. This review highlights the importance of yeasts as an in vivo model for screening viral enzyme inhibitors. We also discuss the advantages of yeast-based screening platforms over traditional assays. Therefore, in the present article, we discuss why yeast is emerging as a model of choice for in vivo screening of anti-viral molecules and why yeast-based screening will become more relevant in the future for screening anti-viral and other molecules of clinical importance.<\/jats:p>","DOI":"10.3390\/microorganisms12030578","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T05:43:30Z","timestamp":1710395010000},"page":"578","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Yeast-Based Screening of Anti-Viral Molecules"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8636-3413","authenticated-orcid":false,"given":"Vartika","family":"Srivastava","sequence":"first","affiliation":[{"name":"Department of Clinical Microbiology and Infectious Diseases, Faculty of Health Sciences, School of Pathology, University of Witwatersrand, Johannesburg 2193, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravinder","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Tennessee Health Science Center, Memphis, TN 38163, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2845-0727","authenticated-orcid":false,"given":"Aijaz","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology and Infectious Diseases, Faculty of Health Sciences, School of Pathology, University of Witwatersrand, Johannesburg 2193, South Africa"},{"name":"Infection Control Unit, Charlotte Maxeke Johannesburg Academic Hospital, National Health Laboratory Service, Johannesburg 2193, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,3,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1042\/BC20070173","article-title":"Viral detection by electron microscopy: Past, present and future","volume":"100","author":"Roingeard","year":"2008","journal-title":"Biol. Cell."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Dubois-Dalcq, M., Holmes, K.V., Rentier, B., and Kingsbury, D.W. (1984). Assembly of Enveloped RNA Viruses, Springer.","DOI":"10.1007\/978-3-7091-8756-2"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00239-019-09913-4","article-title":"Virus\u2013Host Coevolution with a Focus on Animal and Human DNA Viruses","volume":"88","author":"Doszpoly","year":"2020","journal-title":"J. Mol. Evol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Koonin, E.V., Senkevich, T.G., and Dolja, V.V. (2006). The ancient Virus World and evolution of cells. Biol. Direct, 1.","DOI":"10.1186\/1745-6150-1-29"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"12599","DOI":"10.1074\/jbc.R800078200","article-title":"Structural and functional studies of archaeal viruses","volume":"284","author":"Lawrence","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41576-019-0113-7","article-title":"Clinical metagenomics","volume":"20","author":"Chiu","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"9733","DOI":"10.1128\/JVI.00694-10","article-title":"Viral Mutation Rates","volume":"84","author":"Nebot","year":"2010","journal-title":"J. Virol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Crawford, D. (2022). Viruses: A Very Short Introduction, Oxford University Press.","DOI":"10.1093\/actrade\/9780192865069.001.0001"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.tim.2005.04.003","article-title":"Here a virus, there a virus, everywhere the same virus?","volume":"13","author":"Breitbart","year":"2005","journal-title":"Trends Microbiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/s41579-021-00536-5","article-title":"The human virome: Assembly, composition and host interactions","volume":"19","author":"Liang","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"593901","DOI":"10.3389\/fimmu.2020.593901","article-title":"Skin Viral Infections: Host Antiviral Innate Immunity and Viral Immune Evasion","volume":"11","author":"Lei","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/2040622313485275","article-title":"Prevention of infection caused by immunosuppressive drugs in gastroenterology","volume":"4","author":"Orlicka","year":"2013","journal-title":"Ther. Adv. Chronic Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/0022034511400076","article-title":"Mechanisms of Viral Infections Associated with HIV: Workshop 2B","volume":"23","author":"Tugizov","year":"2011","journal-title":"Adv. Dent. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1146\/annurev-genet-120116-023425","article-title":"Human Genetic Determinants of Viral Diseases","volume":"51","author":"Kenney","year":"2017","journal-title":"Annu. Rev. Genet."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1473-3099(21)00648-4","article-title":"Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: A prospective, longitudinal, cohort study","volume":"22","author":"Singanayagam","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.3390\/v7031100","article-title":"The Origin of the Variola Virus","volume":"7","author":"Babkin","year":"2015","journal-title":"Viruses"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nrmicro.2018.11","article-title":"The spread and evolution of rabies virus: Conquering new frontiers","volume":"16","author":"Fisher","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"22311","DOI":"10.1073\/pnas.2010146117","article-title":"Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates","volume":"117","author":"Damas","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41586-020-2334-5","article-title":"Infection of dogs with SARS-CoV-2","volume":"586","author":"Sit","year":"2020","journal-title":"Nature"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"26382","DOI":"10.1073\/pnas.2013102117","article-title":"Experimental infection of domestic dogs and cats with SARS-CoV-2: Pathogenesis, transmission, and response to reexposure in cats","volume":"117","author":"Hartwig","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41579-018-0115-z","article-title":"Host and viral determinants of influenza A virus species specificity","volume":"17","author":"Long","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.3390\/v7042074","article-title":"Can Plant Viruses Cross the Kingdom Border and Be Pathogenic to Humans?","volume":"7","author":"Balique","year":"2015","journal-title":"Viruses"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.virol.2015.02.039","article-title":"Origins and evolution of viruses of eukaryotes: The ultimate modularity","volume":"479\u2013480","author":"Koonin","year":"2015","journal-title":"Virology"},{"key":"ref_24","unstructured":"Centers for Disease Control and Prevention (2022, September 04). NCEZID: Deadly Infections. CDC, Available online: https:\/\/www.cdc.gov\/ncezid\/what-we-do\/our-topics\/deadly-unexplained-diseases.html."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"020421","DOI":"10.7189\/jogh.09.020421","article-title":"Global mortality associated with seasonal influenza epidemics: New burden estimates and predictors from the GLaMOR Project","volume":"9","author":"Paget","year":"2019","journal-title":"J. Glob. Health"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/1941874414533352","article-title":"Poliomyelitis: Historical facts, epidemiology, and current challenges in eradication","volume":"4","author":"Mehndiratta","year":"2014","journal-title":"Neurohospitalist"},{"key":"ref_27","unstructured":"Centers for Disease Control and Prevention (2022, September 04). What is Polio? CDC, Available online: https:\/\/www.cdc.gov\/polio\/what-is-polio\/index.htm."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41569-021-00640-2","article-title":"Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: A global perspective","volume":"19","author":"Halawa","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Sanchez-Ramirez, D.C., Normand, K., Zhaoyun, Y., and Torres-Castro, R. (2021). Long-Term Impact of COVID-19: A Systematic Review of the Literature and Meta-Analysis. Biomedicines, 9.","DOI":"10.3390\/biomedicines9080900"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"16144","DOI":"10.1038\/s41598-021-95565-8","article-title":"More than 50 long-term effects of COVID-19: A systematic review and meta-analysis","volume":"11","author":"Perelman","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_31","unstructured":"Centers for Disease Control and Prevention (2022, September 04). Healthy Habits to Help Protect Against Flu. CDC, Available online: https:\/\/www.cdc.gov\/flu\/prevent\/actions-prevent-flu.htm."},{"key":"ref_32","unstructured":"MAYO CLINIC (2022, September 04). Germs: Understand and Protect against Bacteria, Viruses and Infections. Mayo Clinic. Available online: https:\/\/www.mayoclinic.org\/diseases-conditions\/infectious-diseases\/in-depth\/germs\/art-20045289."},{"key":"ref_33","unstructured":"Centers for Disease Control and Prevention (2022, September 04). How to Protect Yourself and Others, Available online: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/prevent-getting-sick\/prevention.html."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/clinids\/4.5.916","article-title":"Global Eradication of Smallpox","volume":"4","author":"Fenner","year":"1982","journal-title":"Rev. Infect. Dis."},{"key":"ref_35","first-page":"EPDT","article-title":"Polio close to eradication","volume":"114","author":"Norrby","year":"2017","journal-title":"Lakartidningen"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/cei.13517","article-title":"Vaccines for COVID-19","volume":"202","author":"Tregoning","year":"2020","journal-title":"Clin. Exp. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"198114","DOI":"10.1016\/j.virusres.2020.198114","article-title":"COVID-19 Vaccine: A comprehensive status report","volume":"288","author":"Kaur","year":"2020","journal-title":"Virus Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/d41586-020-01221-y","article-title":"The race for coronavirus vaccines: A graphical guide","volume":"580","author":"Callaway","year":"2020","journal-title":"Nature"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1080\/14760584.2022.2053678","article-title":"Thermostable vaccines: An innovative concept in vaccine development","volume":"21","author":"Kumar","year":"2022","journal-title":"Expert Rev. Vaccines"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"foy071","DOI":"10.1093\/femsyr\/foy071","article-title":"Investigating the long-term stability of protein immunogen(s) for whole recombinant yeast-based vaccines","volume":"18","author":"Kumar","year":"2018","journal-title":"FEMS Yeast Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1007\/s00253-021-11259-1","article-title":"Lyophilized yeast powder for adjuvant free thermostable vaccine delivery","volume":"105","author":"Kumar","year":"2021","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"foz007","DOI":"10.1093\/femsyr\/foz007","article-title":"Yeast-based vaccines: New perspective in vaccine development and application","volume":"19","author":"Kumar","year":"2019","journal-title":"FEMS Yeast Res."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Srivastava, V., Nand, K.N., Ahmad, A., and Kumar, R. (2023). Yeast-Based Virus-like Particles as an Emerging Platform for Vaccine Development and Delivery. Vaccines, 11.","DOI":"10.3390\/vaccines11020479"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Kumar, R., and Srivastava, V. (2023). Application of anti-fungal vaccines as a tool against emerging anti-fungal resistance. Front. Fungal Biol., 4.","DOI":"10.3389\/ffunb.2023.1241539"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.cell.2020.06.043","article-title":"Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus","volume":"182","author":"Korber","year":"2020","journal-title":"Cell"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1038\/s41467-021-24285-4","article-title":"COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants","volume":"12","author":"Jalkanen","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/s41467-022-28882-9","article-title":"Cryo-EM structure of a SARS-CoV-2 omicron spike protein ectodomain","volume":"13","author":"Ye","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/s41467-022-28324-6","article-title":"Structural and biochemical rationale for enhanced spike protein fitness in delta and kappa SARS-CoV-2 variants","volume":"13","author":"Saville","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1056\/NEJMoa2201688","article-title":"Fourth Dose of BNT162b2 mRNA COVID-19 Vaccine in a Nationwide Setting","volume":"386","author":"Magen","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_50","first-page":"n1931","article-title":"Risk of thrombocytopenia and thromboembolism after COVID-19 vaccination and SARS-CoV-2 positive testing: Self-controlled case series study","volume":"374","author":"Patone","year":"2021","journal-title":"BMJ"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e070650","DOI":"10.1136\/bmj-2022-070650","article-title":"It is not too late to achieve global COVID-19 vaccine equity","volume":"376","author":"Yamey","year":"2022","journal-title":"BMJ"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1080\/14760584.2022.2067146","article-title":"Immunization in state of siege: The importance of thermostable vaccines for Ukraine and other war-torn countries and territories","volume":"21","author":"Tsagkaris","year":"2022","journal-title":"Expert Rev. Vaccines"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1080\/14760584.2022.2067147","article-title":"Response to: \u201cimmunization  in state of siege: The importance of thermostable vaccines for Ukraine and other war-torn countries and territories\u201d","volume":"21","author":"Kumar","year":"2022","journal-title":"Expert Rev. Vaccines"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.3390\/covid3120121","article-title":"The Two Sides of the COVID-19 Pandemic","volume":"3","author":"Kumar","year":"2023","journal-title":"COVID"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4269\/ajtmh.1988.38.172","article-title":"A Prospective Study of Dengue Infections in Bangkok","volume":"38","author":"Burke","year":"1988","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4269\/ajtmh.1988.38.411","article-title":"Evidence That Maternal Dengue Antibodies Are Important in the Development of Dengue Hemorrhagic Fever in Infants","volume":"38","author":"Kliks","year":"1988","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"590780","DOI":"10.3389\/fimmu.2020.590780","article-title":"Major Scientific Hurdles in HIV Vaccine Development: Historical Perspective and Future Directions","volume":"11","author":"Chasara","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3201\/eid1201.051068","article-title":"Vaccines and Antiviral Drugs in Pandemic Preparedness","volume":"12","author":"Monto","year":"2006","journal-title":"Emerg. Infect. Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/s41551-020-00658-w","article-title":"Development of vaccines and antivirals for combating viral pandemics","volume":"4","author":"Pardi","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Lee, J.T., Yang, Q., Gribenko, A., Perrin, B.S., Zhu, Y., Cardin, R., Liberator, P.A., Anderson, A.S., and Hao, L. (2022). Genetic Surveillance of SARS-CoV-2 M pro Reveals High Sequence and Structural Conservation Prior to the Introduction of Protease Inhibitor Paxlovid. mBio, 13.","DOI":"10.1128\/mbio.00869-22"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"105360","DOI":"10.1016\/j.antiviral.2022.105360","article-title":"Conserved coronavirus proteins as targets of broad-spectrum antivirals","volume":"204","author":"Bobrowski","year":"2022","journal-title":"Anti-Viral Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2217\/fvl.12.56","article-title":"The molecular biology of HIV integrase","volume":"7","author":"Craigie","year":"2012","journal-title":"Future Virol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1742-4690-5-114","article-title":"Integrase and integration: Biochemical activities of HIV-1 integrase","volume":"5","author":"Delelis","year":"2008","journal-title":"Retrovirology"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s12967-020-02439-0","article-title":"Analysis of SARS-CoV-2 RNA-dependent RNA polymerase as a potential therapeutic drug target using a computational approach","volume":"18","author":"Aftab","year":"2020","journal-title":"J. Transl. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"149642","DOI":"10.1016\/j.scitotenv.2021.149642","article-title":"Estimation of COVID-19 generated medical waste in the Kingdom of Bahrain","volume":"801","author":"Khan","year":"2021","journal-title":"Sci. Total Environ."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"100005","DOI":"10.1016\/j.joclim.2021.100005","article-title":"Eco-friendly vaccination: Tackling an unforeseen adverse effect","volume":"1","author":"Phadke","year":"2021","journal-title":"J. Clim. Chang. Health"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"146220","DOI":"10.1016\/j.scitotenv.2021.146220","article-title":"COVID-19 pandemic and healthcare solid waste management strategy\u2014A mini-review","volume":"778","author":"Das","year":"2021","journal-title":"Sci. Total. Environ."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1620\/tjem.237.45","article-title":"A Synthetic Serine Protease Inhibitor, Nafamostat Mesilate, Is a Drug Potentially Applicable to the Treatment of Ebola Virus Disease","volume":"237","author":"Nishimura","year":"2015","journal-title":"Tohoku J. Exp. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1021\/acs.jcim.1c01087","article-title":"Screening for Inhibitors of Main Protease in SARS-CoV-2: In Silico and In Vitro Approach Avoiding Peptidyl Secondary Amides","volume":"62","author":"Yamamoto","year":"2022","journal-title":"J. Chem. Inf. Model."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Cihlova, B., Huskova, A., B\u00f6serle, J., Nencka, R., Boura, E., and Silhan, J. (2021). High-Throughput Fluorescent Assay for Inhibitor Screening of Proteases from RNA Viruses. Molecules, 26.","DOI":"10.3390\/molecules26133792"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Coelho, C., Gallo, G., Campos, C.B., Hardy, L., and W\u00fcrtele, M. (2020). Biochemical screening for SARS-CoV-2 main protease inhibitors. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0240079"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Graudejus, O., Wong, R.D.P., Varghese, N., Wagner, S., and Morrison, B. (2018). Bridging the gap between in vivo and in vitro research: Reproducing in vitro the mechanical and electrical environment of cells in vivo. Front. Cell. Neurosci., 12.","DOI":"10.3389\/conf.fncel.2018.38.00069"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1021\/acsptsci.0c00130","article-title":"Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin Are Nonspecific Promiscuous SARS-CoV-2 Main Protease Inhibitors","volume":"3","author":"Ma","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1021\/acscentsci.1c00519","article-title":"Discovery of SARS-CoV-2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay","volume":"7","author":"Ma","year":"2021","journal-title":"ACS Central Sci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.3389\/fphar.2019.01484","article-title":"In Vitro Research Reproducibility: Keeping Up High Standards","volume":"10","author":"Hirsch","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.slasd.2023.01.001","article-title":"High throughput screening for drugs that inhibit 3C-like protease in SARS-CoV-2","volume":"28","author":"Smith","year":"2023","journal-title":"SLAS Discov."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abl4784","article-title":"An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19","volume":"374","author":"Owen","year":"2021","journal-title":"Science"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1016\/j.apsb.2022.02.002","article-title":"Why 90% of clinical drug development fails and how to improve it?","volume":"12","author":"Sun","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.str.2010.08.007","article-title":"Transient Protein-Protein Interactions: Structural, Functional, and Network Properties","volume":"18","author":"Perkins","year":"2010","journal-title":"Structure"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/cyto.a.22851","article-title":"Overcoming limitations of FRET measurements","volume":"89","author":"Leavesley","year":"2016","journal-title":"Cytom. Part A"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4014\/jmb.1508.08007","article-title":"Cell-Based Assay Design for High-Content Screening of Drug Candidates","volume":"26","author":"Nierode","year":"2016","journal-title":"J. Microbiol. Biotechnol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"187","DOI":"10.14573\/altex.2009.3.187","article-title":"Re-evaluation of animal numbers and costs for in vivo tests to accomplish REACH legislation requirements for chemicals\u2014A report by the transatlantic think tank for toxicology (t(4))","volume":"26","author":"Rovida","year":"2009","journal-title":"ALTEX"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1126\/science.278.5340.1064","article-title":"Integrating Genetic Approaches into the Discovery of Anticancer Drugs","volume":"278","author":"Hartwell","year":"1997","journal-title":"Science"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Peterson, T.A., Park, D., and Kann, M.G. (2013). A protein domain-centric approach for the comparative analysis of human and yeast phenotypically relevant mutations. BMC Genom., 14.","DOI":"10.1186\/1471-2164-14-S3-S5"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"311","DOI":"10.15698\/mic2017.10.592","article-title":"Yeast for virus research","volume":"4","author":"Zhao","year":"2017","journal-title":"Microb. Cell"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1475-2859-6-32","article-title":"Saccharomyces cerevisiae: A versatile eukaryotic system in virology","volume":"6","author":"Galao","year":"2007","journal-title":"Microb. Cell Factories"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1007\/s00253-021-11331-w","article-title":"Contribution of yeast models to virus research","volume":"105","author":"Glingston","year":"2021","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1534\/genetics.114.161620","article-title":"The Yeast Deletion Collection: A Decade of Functional Genomics","volume":"197","author":"Giaever","year":"2014","journal-title":"Genetics"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"D1245","DOI":"10.1093\/nar\/gky941","article-title":"YeastRGB: Comparing the abundance and localization of yeast proteins across cells and libraries","volume":"47","author":"Dubreuil","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1534\/genetics.114.163188","article-title":"Budding Yeast for Budding Geneticists: A Primer on the Saccharomyces cerevisiae Model System","volume":"197","author":"Duina","year":"2014","journal-title":"Genetics"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U","article-title":"Additional modules for versatile and economical PCR-based gene deletion and modification in Saccharomyces cerevisiae","volume":"14","author":"Longtine","year":"1998","journal-title":"Yeast"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1124\/mol.107.044651","article-title":"Enhancing Drug Accumulation in Saccharomyces cerevisiae by Repression of Pleiotropic Drug Resistance Genes with Chimeric Transcription Repressors","volume":"74","author":"Stepanov","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1128\/AAC.44.2.418-420.2000","article-title":"Role of the PDR Gene Network in Yeast Susceptibility to the Antifungal Antibiotic Mucidin","volume":"44","author":"Obernauerova","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"R40","DOI":"10.1093\/hmg\/ddu125","article-title":"CRISPR\/Cas9 for genome editing: Progress, implications and challenges","volume":"23","author":"Zhang","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jsps.2013.11.002","article-title":"Alternatives to animal testing: A review","volume":"23","author":"Doke","year":"2015","journal-title":"Saudi Pharm. J."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Cressey, D. (2014). UK \u2018absolutely committed\u2019 to reducing animal use in research. Nature.","DOI":"10.1038\/nature.2014.14688"},{"key":"ref_97","unstructured":"United States Environmental Protection Agency (2022, September 04). EPA New Approach Methods: Efforts to Reduce Use of Vertebrate Animals in Chemical Testing. EPA, Available online: https:\/\/www.epa.gov\/research\/epa-new-approach-methods-efforts-reduce-use-vertebrate-animals-chemical-testing."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.drudis.2020.12.009","article-title":"Artificial intelligence in drug discovery: What is realistic, what are illusions? Part 1: Ways to make an impact, and why we are not there yet","volume":"26","author":"Bender","year":"2021","journal-title":"Drug Discov. Today"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0006-291X(02)02995-9","article-title":"A yeast assay for high throughput screening of natural anti-viral agents","volume":"301","author":"Srivastava","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1128\/AAC.50.2.565-571.2006","article-title":"Novel Yeast Cell-Based Assay to Screen for Inhibitors of Human Cytomegalovirus Protease in a High-Throughput Format","volume":"50","author":"Cottier","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jviromet.2013.08.019","article-title":"Yeast cells as a tool for analysis of HIV-1 protease susceptibility to protease inhibitors, a comparative study","volume":"195","author":"Ravaux","year":"2014","journal-title":"J. Virol. Methods"},{"key":"ref_102","first-page":"151","article-title":"Fission yeast as a HTS platform for molecular probes of HIV-1 Vpr-induced cell death","volume":"1","author":"Benko","year":"2010","journal-title":"Int. J. High Throughput Screen."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Frieman, M., Basu, D., Matthews, K., Taylor, J., Jones, G., Pickles, R., Baric, R., and Engel, D.A. (2011). Yeast Based Small Molecule Screen for Inhibitors of SARS-CoV. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0028479"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"e0108721","DOI":"10.1128\/mSystems.01087-21","article-title":"A Genetic Trap in Yeast for Inhibitors of SARS-CoV-2 Main Protease","volume":"6","author":"Alalam","year":"2021","journal-title":"mSystems"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.antiviral.2014.02.002","article-title":"Yeast-based assays for the high-throughput screening of inhibitors of coronavirus RNA cap guanine-N7-methyltransferase","volume":"104","author":"Sun","year":"2014","journal-title":"Antivir. Res."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1093\/nar\/gkr382","article-title":"A rapid, inexpensive yeast-based dual-fluorescence assay of programmed\u20141 ribosomal frameshifting for high-throughput screening","volume":"39","author":"Liao","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"e77433","DOI":"10.7554\/eLife.77433","article-title":"Comprehensive fitness landscape of SARS-CoV-2 Mpro reveals insights into viral resistance mechanisms","volume":"11","author":"Flynn","year":"2022","journal-title":"eLife"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Zhang, J., Vernon, K., Li, Q., Benko, Z., Amoroso, A., Nasr, M., and Zhao, R.Y. (2021). Single-Agent and Fixed-Dose Combination HIV-1 Protease Inhibitor Drugs in Fission Yeast (Schizosaccharomyces pombe). Pathogens, 10.","DOI":"10.3390\/pathogens10070804"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Benko, Z., Elder, R.T., Li, G., Liang, D., and Zhao, R.Y. (2016). HIV-1 Protease in the Fission Yeast Schizosaccharomyces pombe. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0151286"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Benko, Z., Liang, D., Li, G., Elder, R.T., Sarkar, A., Takayama, J., Ghosh, A.K., and Zhao, R.Y. (2017). A fission yeast cell-based system for multidrug resistant HIV-1 proteases. Cell Biosci., 7.","DOI":"10.1186\/s13578-016-0131-5"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"e56649","DOI":"10.7554\/eLife.56649","article-title":"Assigning mitochondrial localization of dual localized proteins using a yeast Bi-Genomic Mitochondrial-Split-GFP","volume":"9","author":"Bader","year":"2020","journal-title":"eLife"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10930-006-9051-2","article-title":"A Split Enhanced Green Fluorescent Protein-Based Reporter in Yeast Two-Hybrid System","volume":"26","author":"Park","year":"2007","journal-title":"Protein J."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s12033-021-00299-7","article-title":"Cell-Based High-Throughput Screening Protocol for Discovering Antiviral Inhibitors Against SARS-CoV-2 Main Protease (3CLpro)","volume":"63","author":"Rothan","year":"2021","journal-title":"Mol. Biotechnol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.apsb.2021.10.026","article-title":"Validation and invalidation of SARS-CoV-2 main protease inhibitors using the Flip-GFP and Protease-Glo luciferase assays","volume":"12","author":"Ma","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Castell\u00f3, A., \u00c1lvarez, E., and Carrasco, L. (2011). The Multifaceted Poliovirus 2A Protease: Regulation of Gene Expression by Picornavirus Proteases. J. Biomed. Biotechnol., 2011.","DOI":"10.1155\/2011\/369648"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1099\/0022-1317-71-11-2553","article-title":"Cleavage specificity of the poliovirus 3C protease is not restricted to Gln-Gly at the 3C\/3D junction","volume":"71","author":"Kean","year":"1990","journal-title":"J. Gen. Virol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"39470","DOI":"10.1074\/jbc.M112.388678","article-title":"Activity, Specificity, and Probe Design for the Smallpox Virus Protease K7L","volume":"287","author":"Aleshin","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Lin, M.-H., Chuang, S.-J., Chen, C.-C., Cheng, S.-C., Cheng, K.-W., Lin, C.-H., Sun, C.-Y., and Chou, C.-Y. (2014). Structural and functional characterization of MERS coronavirus papain-like protease. J. Biomed. Sci., 21.","DOI":"10.1186\/1423-0127-21-54"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrd.2015.37","article-title":"Coronaviruses\u2014Drug discovery and therapeutic options","volume":"15","author":"Zumla","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"11348","DOI":"10.1021\/cr500233q","article-title":"Biochemistry and Medicinal Chemistry of the Dengue Virus Protease","volume":"114","author":"Nitsche","year":"2014","journal-title":"Chem. Rev."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"14023","DOI":"10.1021\/bi9712697","article-title":"Active Site Cavity of Herpesvirus Proteases Revealed by the Crystal Structure of Herpes Simplex Virus Protease\/Inhibitor Complex","volume":"36","author":"Hoog","year":"1997","journal-title":"Biochemistry"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1073\/pnas.94.7.2874","article-title":"Crystal structure of varicella-zoster virus protease","volume":"94","author":"Qiu","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1128\/JVI.72.5.4463-4466.1998","article-title":"The Rubella Virus Nonstructural Protease Requires Divalent Cations for Activity and Functions in trans","volume":"72","author":"Liu","year":"1998","journal-title":"J. Virol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/978-981-10-8727-1_10","article-title":"The Structure of the Zika Virus Protease, NS2B\/NS3pro","volume":"1062","author":"Hilgenfeld","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.4155\/fmc.13.89","article-title":"Understanding HIV-1 protease autoprocessing for novel therapeutic development","volume":"5","author":"Huang","year":"2013","journal-title":"Future Med. Chem."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1074\/jbc.M205636200","article-title":"Cell Killing by HIV-1 Protease","volume":"278","author":"Blanco","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1128\/MCB.20.4.1271-1277.2000","article-title":"Poliovirus 2A Protease Induces Apoptotic Cell Death","volume":"20","author":"Goldstaub","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Komissarov, A.A., Karaseva, M.A., Roschina, M.P., Shubin, A.V., Lunina, N.A., Kostrov, S.V., and Demidyuk, I.V. (2021). Individual Expression of Hepatitis A Virus 3C Protease Induces Ferroptosis in Human Cells In Vitro. Int. J. Mol. Sci., 22.","DOI":"10.1101\/2021.05.28.446108"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/02648725.2000.10647993","article-title":"Production of Active Mammalian and Viral Proteases in Bacterial Expression Systems","volume":"17","author":"Linneversl","year":"2000","journal-title":"Biotechnol. Genet. Eng. Rev."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nmeth.1401","article-title":"An auxin-based degron system for the rapid depletion of proteins in nonplant cells","volume":"6","author":"Nishimura","year":"2009","journal-title":"Nat. Methods"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jprot.2014.06.006","article-title":"Comparative proteomics of mitosis and meiosis in Saccharomyces cerevisiae","volume":"109","author":"Kumar","year":"2014","journal-title":"J. Proteom."},{"key":"ref_132","first-page":"5368","article-title":"Potential use of Pichia pastoris strain SMD1168H expressing DNA topoisomerase I in the screening of potential anti-breast cancer agents","volume":"19","author":"Jian","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Kumar, R., Rahman, M.A., and Nazarko, T.Y. (2020). Nitrogen Starvation and Stationary Phase Lipophagy Have Distinct Molecular Mechanisms. Int. J. Mol. Sci., 21.","DOI":"10.1101\/2020.03.17.996082"},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Kumar, R., Shroff, A., and Nazarko, T.Y. (2022). Komagataella phaffii Cue5 Piggybacks on Lipid Droplets for Its Vacuolar Degradation during Stationary Phase Lipophagy. Cells, 11.","DOI":"10.3390\/cells11020215"},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Bernauer, L., Radkohl, A., Lehmayer, L.G.K., and Emmerstorfer-Augustin, A. (2021). Komagataella phaffii as Emerging Model Organism in Fundamental Research. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.607028"},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Wijewantha, N.V., Kumar, R., and Nazarko, T.Y. (2024). Glycogen Granules Are Degraded by Non-Selective Autophagy in Nitrogen-Starved Komagataella phaffii. Cells, 13.","DOI":"10.3390\/cells13060467"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1017\/S0031182013000425","article-title":"The utility of yeast as a tool for cell-based, target-directed high-throughput screening","volume":"141","author":"Norcliffe","year":"2014","journal-title":"Parasitology"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.3346\/jkms.2020.35.e123","article-title":"Drive-Through Screening Center for COVID-19: A Safe and Efficient Screening System against Massive Community Outbreak","volume":"35","author":"Kwon","year":"2020","journal-title":"J. Korean Med. Sci."}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/12\/3\/578\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:13:16Z","timestamp":1760105596000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/12\/3\/578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,14]]},"references-count":138,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["microorganisms12030578"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms12030578","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,14]]}}}